Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Stem cells ‘could be used as an alternative to antibiotics’
"...MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Study finds MSCs in horses fight bacterial infection 

Stem cells found in horses naturally produce molecules that can fight bacterial infection, according to new research by the Roslin Institute.

The team examined mesenchymal stem cells (MSCs), which are seen in animals and humans and can differentiate into a variety of cell types.

They discovered that MSCs may be able to fight infection in two ways - by acting directly on bacteria and by regulating the activity of immune cells involved in the body’s natural defences.

The endometrium was identified as a particularly promising novel source of MSCs for clinical applications in horses - and likely in other species too.

MSCs obtained from bone marrow or adipose tissue have been used for clinical tissue regeneration in animals for more than 10 years, which scientists say assures their safe use as potential clinical antimicrobials in the future.

Lead author Dr Cristina Esteves said: “This study shows that equine MSCs may act to defend the body against bacterial infection.

"We’re excited about these results as MSCs could prove useful against antimicrobial resistance and be used as an alternative to antibiotics.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.